Kairos Pharma, Ltd. (AMEX: KAPA) last traded at $0.290, down 1.73% on the session. The quote above updates while this page is open; the figures below are drawn from Kairos Pharma, Ltd.’s own filings and are restated only when a new one is published.
Kairos Pharma, Ltd. trades on AMEX under the ticker KAPA. Its market capitalisation is $6.87 million.
Valuation measures for Kairos Pharma, Ltd., derived from the latest quote and its most recent SEC filing.
| Market cap | $6.87M |
|---|---|
| Price / book | 1.64 |
| Beta | 1.68 |
Trailing-twelve-month figures tagged in Kairos Pharma, Ltd.'s XBRL filings with the SEC.
| Net income (TTM) | -$5.80M |
|---|---|
| EPS (TTM) | -$0.280 |
| Return on equity | -138.51% |
| Cash | $2.63M |
Range and volume for KAPA over the past 52 weeks.
| 52-week high | $2.11 |
|---|---|
| 52-week low | $0.270 |
| Volume | 110.6K |
| Average volume | 2.16M |
| Previous close | $0.295 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.